MFN reinforces the worst incentives in 340B, shifts costs to patients and employers, and threatens the long-term health of both public programs and private enterprise. It’s a budget sleight-of-hand wrapped in bad economics.
Congressional Republicans are under pressure to find savings to make the math in their budget reconciliation package add up.
Medicaid, which accounts for just under 10% of federal spending, has become an obvious target. But instead of addressing the flawed incentives driving the program’s unsustainability, the Trump administration is pushing for a “most favored nation,” or MFN, policy on drug pricing…
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.
A Most Flawed Notion: Medicaid ‘Fix’ Will Worsen 340B Crisis
Sally C. Pipes
MFN reinforces the worst incentives in 340B, shifts costs to patients and employers, and threatens the long-term health of both public programs and private enterprise. It’s a budget sleight-of-hand wrapped in bad economics.
Congressional Republicans are under pressure to find savings to make the math in their budget reconciliation package add up.
Medicaid, which accounts for just under 10% of federal spending, has become an obvious target. But instead of addressing the flawed incentives driving the program’s unsustainability, the Trump administration is pushing for a “most favored nation,” or MFN, policy on drug pricing…
This isn’t reform. It’s a gimmick.
Read the op-ed.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.